The Secret Circular World of Genetic Regulation
From biological curiosity to medical frontier
In the fascinating world of molecular biology, where linear DNA molecules and their RNA transcripts have long been the center of attention, a surprising architectural alternative has emerged—circular RNAs. These mysterious circular molecules, once dismissed as mere splicing errors, have now revolutionized our understanding of genetic regulation and opened new frontiers in medical science. Unlike their linear counterparts, circular RNAs form covalently closed loops without the traditional beginning and end, making them remarkably stable and capable of unique biological functions 1 .
Circular RNAs (circRNAs) are a unique class of RNA molecules characterized by their covalently closed circular structure. Unlike linear RNAs, they lack the traditional 5' cap and 3' poly(A) tail, which makes them exceptionally resistant to degradation by cellular exonucleases. This structural stability allows them to persist in cells for much longer than most linear RNAs, making them ideal candidates for cellular regulation and potential therapeutic applications 1 6 .
The transformation in our understanding of circular RNAs represents one of the most dramatic shifts in modern molecular biology. Initially dismissed as transcriptional noise, circular RNAs are now recognized as important regulators of gene expression with tissue-specific distribution and evolutionary conservation across species 1 .
First suspicion of circular RNAs when scientists discovered plant viroids consisted of single-stranded circular RNA molecules 3 .
First observation of circular RNAs in mammalian cells, specifically in a tumor suppressor gene called DCC 3 .
Technological advances revealed the abundance and functional significance of circular RNAs, transforming our understanding 6 .
The formation of circular RNAs is a remarkable example of molecular origami that defies traditional splicing rules. While linear RNAs are produced through canonical splicing (joining 5' donor to 3' acceptor sites), circular RNAs are generated through a process called backsplicing, where a downstream 5' splice site joins with an upstream 3' splice site 1 6 .
Complementary sequences within introns flanking the circularized exons base-pair with each other 3 .
Exon skipping events can generate lariat structures containing exons, which then undergo internal splicing 3 .
| Type | Composition | Cellular Location | Primary Functions |
|---|---|---|---|
| exonic circRNAs (ecircRNAs) | Exons only | Cytoplasm | miRNA sponging, protein binding |
| exon-intron circRNAs (EIciRNAs) | Both exons and introns | Nucleus | Regulating transcription |
| circular intronic RNAs (ciRNAs) | Introns only | Nucleus | Modulating transcription |
| tRNA intronic circRNAs (tricRNAs) | tRNA introns | Cytoplasm | Unknown regulatory functions |
Table 1: Types of Circular RNAs and Their Characteristics 3 6
One of the most well-established functions of circular RNAs is their role as microRNA sponges. These circular molecules contain multiple binding sites for specific microRNAs, effectively sequestering them and preventing them from targeting their natural mRNA targets. This "sponging" activity allows circular RNAs to indirectly regulate gene expression by modulating microRNA activity 1 9 .
The most famous example of this sponge function is CDR1as (also known as ciRS-7), which contains more than 70 conserved binding sites for miR-7 and is highly expressed in human and mouse brains 3 6 .
Circular RNAs can bind to proteins and alter their function, serve as scaffolds for assembling multiprotein complexes, and regulate transcription through interactions with RNA polymerase II 3 .
The role of circular RNAs in cancer represents one of the most actively researched areas in the field. Generally, circular RNAs tend to be downregulated in tumor tissue compared to normal tissue, which may result from errors in the back-splice machinery in malignant tissues, degradation by deregulated miRNAs, or reduced stability due to increased cell proliferation 1 .
| circRNA | Cancer Type | Function | Mechanism |
|---|---|---|---|
| circPVT1 | Head and neck squamous cell carcinoma | Oncogenic | Sponges miR-497-5p, regulates proliferation genes |
| circHIPK3 | Nasopharyngeal carcinoma | Oncogenic | Promotes cancer progression |
| circ-FBXW7 | Glioblastoma | Tumor suppressor | Encodes FBXW7-185aa protein that inhibits c-Myc |
| circ-ITCH | Various cancers | Tumor suppressor | Sponges miRNAs that target tumor suppressors |
Table 2: Examples of Circular RNAs Involved in Human Cancers 3 9
circRNAs are highly abundant in neuronal tissues and have been linked to Alzheimer's disease 3 .
Multiple circRNAs have been associated with myocardial infarction, cardiac hypertrophy, and fibrosis .
CircGLIS3(2) increases in skin fibroblasts after injury and promotes tissue rebuilding 7 .
One of the most significant technical advances in circular RNA research comes from a landmark study published in Nature Communications in 2025, which developed a novel method for chemically circularizing in vitro transcribed RNAs of various lengths (35-4000 nucleotides) with circularization efficiencies reaching up to 60% 8 .
This innovative approach, called chemical circularization, leverages a 5' ethylenediamine modification and a periodate-oxidized 3' end to drive intramolecular reductive amination. This process forms a morpholine-derived inter-nucleotide linkage that creates a stable circular structure 8 .
| Method | Efficiency | Limitations | Advantages |
|---|---|---|---|
| Chemical circularization | Up to 60% | Requires specialized primers | Sequence flexibility, modification compatibility |
| Enzymatic ligation | Variable | Sequence constraints, purification challenges | Biological compatibility |
| Ribozymatic circularization | Variable | Incompatible with modified bases | No enzyme requirement |
| Group I/II intron circularization | Variable | Specific sequence requirements | High fidelity in vivo circularization |
Table 3: Comparison of Circularization Methods 8
The study of circular RNAs requires specialized reagents and methodologies that have been developed and refined over recent years. Here we highlight key research reagent solutions that enable circular RNA discovery and characterization:
The journey of circular RNAs from dismissed artifacts to key regulatory molecules represents one of the most exciting developments in molecular biology in recent decades. These stable, abundant, and versatile molecules have been revealed as important players in virtually all aspects of cellular function and in numerous disease processes 1 9 .
The circular RNA revolution reminds us that scientific humility is essential—what we once dismissed as cellular debris often turns out to be biological treasure.